Buparvex is indicated for the treatment of Zimbabwean theileriosis (January Disease) caused by Theileria bovis and Buffalo derived theileriosis during outbreaks. It may be used in the incubation period of the disease or when clinical signs are apparent.
| Effective Use | Theileriosis (January Disease) |
| For Use On | Beef Cattle, Dairy Cattle |
| Contents | Buparvaquone 50mg/ml |
| Pack Size | 50ml |
| Directions for Use | Dose: A single injection of 1ml Buparvex per 20kg bodyweight is usually sufficient. Intramuscular injection into the muscles of the neck is recommended observing normal aseptic precautions. In severe cases a second treatment may be given within 48-72 hours of the initial injection if not clear signs of improvement are shown. Symptomatic treatment using diuretics, vitamins and broad spectrum antibiotics may be useful in accelerating recovery. |
| Withdrawal Period | Meat: 42 days Milk: 24 hours
|
| Precautions | Do not inject more than 20ml per injection site. Not to be used in cattle with impaired renal function. Recovery of animals may remain carriers of theileriosis. Theileriosis has a severe depressant effect on the immune system – any vaccines should be delayed until animal has recovered |